A phase II/III trial to evaluate ADXS-HPV in combination with chemotherapy and radiation in high-risk locally advanced anal cancer

Trial Profile

A phase II/III trial to evaluate ADXS-HPV in combination with chemotherapy and radiation in high-risk locally advanced anal cancer

Planning
Phase of Trial: Phase II/III

Latest Information Update: 24 Jul 2015

At a glance

  • Drugs Axalimogene filolisbac (Primary) ; Fluorouracil; Mitomycin
  • Indications Anal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2015 New trial record
    • 25 Jun 2015 According to an Advaxis media release, data from this trial will be available in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top